MyChesCo on MSN8h
New Hypertension Treatment TRYVIO Now Available in the U.S.
RADNOR, PA — Idorsia Pharmaceuticals U.S. Inc. has announced the availability of TRYVIO™ (aprocitentan) in the United States ...
Monthly Prescribing Reference1d
Tryvio Now Available for Difficult-to-Control Hypertension
Tryvio TM (aprocitentan) is now available for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure (BP) in adult patients who are not adequately ...
pharmaphorum2d
Idorsia first-in-class hypertension drug gets FDA okay
Aprocitentan will be sold under the Tryvio brand name in the US and will be an add-on option for patients who can’t control their blood pressure using other therapies. It represents the first ...
Hosted on MSN7mon
FDA Approves the First New Type of High Blood Pressure Drug In Decades
The FDA approved a new treatment for uncontrolled high blood pressure. The once-daily oral medication, called Tryvio (aprocitentan), is expected to be available in the second half of 2024.
Idorsia upgraded to Hold from Sell at Deutsche Bank
Deutsche Bank analyst Emmanuel Papadakis upgraded Idorsia (IDRSF) to Hold from Sell with an unchanged price target of CHF 1. The firm thinks ...
Finanznachrichten1y
Idorsia Pharmaceuticals Ltd: Idorsia announces financial results for the first nine months of 2024
QUVIVIQ approved for the treatment of insomnia in Japan. TRYVIO (aprocitentan) commercially available in the US since October 2024. JERAYGO (aprocitentan) approved by the European Commission in ...